These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Search MEDLINE/PubMed

  • Title: [Minimal invasive surgery in the treatment of neuroendocrine tumors of the pancreas].
    Author: Zhu QC, Mou YP.
    Journal: Zhonghua Wai Ke Za Zhi; 2018 Nov 01; 56(11):877-880. PubMed ID: 30392310.
    Abstract:
    Neuroendocrine tumor of the pancreas (pNET) is a rare group of neoplasms with widely heterogeneity. Complete surgical resection remains the only potentially curative treatment for pNET. Compared to open surgery, minimal invasive approach treating pNET could decrease bleeding and shorten postoperative hospital stay, while didn't show difference in operation time, postoperative complication rate and overall mortality. Therapeutic strategy was formulated by synthesizing clinical symptoms, tumor size and tumor stage. Minimal invasive approach can achieve radical curve of oncology and provide refine manipulation condition to improve surgical safety and efficacy, meanwhile realize function preservation. Minimal invasive approach is a safe and efficient method in treating pNET, but further prospective, randomized control trials are required. 胰腺神经内分泌肿瘤是罕见的异质性肿瘤，手术切除是唯一可能治愈的方式。微创技术治疗胰腺神经内分泌肿瘤术中出血量少、术后住院时间短，在手术时间、术后并发症发生率及总体病死率等方面与开放手术相比无差异。治疗策略需要综合临床症状、肿瘤大小、肿瘤分级分期等信息制定。微创技术既能达到肿瘤学根治，也能为术者提供精细操作的条件，提高手术的安全性和有效性，并实现器官功能保留，是治疗胰腺神经内分泌肿瘤安全可行的手段，但仍需要前瞻性随机对照研究结果进一步证实。.
    [Abstract] [Full Text] [Related] [New Search]